Global Oncology Academy
Popular
Pavani Chalasani, MD, MPH
Alison Stopeck, MD
- On the Frontlines of Metastatic Breast Cancer
Modern Approaches to Long-Term Metastatic Breast Cancer Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Brufsky, MD, PhD
- On the Frontlines of Metastatic Breast Cancer
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
Charles Turck, PharmD, BCPS, BCCCP
Jules Cohen, MD
- On the Frontlines of Metastatic Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Jules Cohen, MD
Pavani Chalasani, MD, MPH
Kristina Fanucci, MD, MHS
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
Charles Turck, PharmD, BCPS, BCCCP
Andrea Necchi, MD
Medical News
- 01/12/2026
- Medical NewsEmerging Innovations in Cellular and Antibody Immunotherapies: Cancer Treatment Redefined01/12/2026
- 01/07/2026
CME/CE
Ryan D. Cassaday, MD
Daniel J. DeAngelo, MD, PhD
Michiel van de Sande, MD, PhD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
Clinical Practice
- On the Frontlines of Metastatic Breast Cancer
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Ashley Baker, MSN, PMHNP
Nick McAndrew, MD, MSCE
Jennifer Caudle, DO, FACOFP
Maxwell Llyod, MD
- Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Alexandria May, PharmD, BCPS
Nicholas Whipple, MD, MPH
Seth Wander, MD, PhD
Programs
- On the Frontlines of Metastatic Breast Cancer
Tracking Tumor Resistance in Metastatic Breast Cancer Care
Ryan Quigley
Megan Kruse, MD
Marlene Mimi Maeusli, PhD.
Brian P. McDonough, MD, FAAFP
Matthew Galsky, MD
Ryan Quigley
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami